ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,217 | -54.3% | 18,790 | -39.8% | 0.00% | -50.0% |
| Q1 2023 | $94,533 | +1.1% | 31,199 | -22.3% | 0.01% | +20.0% |
| Q4 2022 | $93,547 | -9.2% | 40,149 | -25.5% | 0.01% | +25.0% |
| Q3 2022 | $103,000 | -44.6% | 53,877 | -21.4% | 0.00% | -20.0% |
| Q2 2022 | $186,000 | +5.1% | 68,565 | +15.2% | 0.01% | 0.0% |
| Q1 2022 | $177,000 | +2.9% | 59,500 | +34.3% | 0.01% | +25.0% |
| Q4 2021 | $172,000 | +3.0% | 44,300 | +13.6% | 0.00% | 0.0% |
| Q3 2021 | $167,000 | -48.0% | 39,000 | -56.9% | 0.00% | -50.0% |
| Q4 2020 | $321,000 | +13.8% | 90,400 | +0.4% | 0.01% | -42.9% |
| Q3 2020 | $282,000 | +1242.9% | 90,000 | +2547.1% | 0.01% | +600.0% |
| Q3 2017 | $21,000 | – | 3,400 | +3300.0% | 0.00% | – |
| Q2 2016 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |